Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Singkome Tima, Siriporn Okonogi, Chadarat Ampasavate, Cory Berkland & Songyot Anuchapreeda. (2019) FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells. Drug Development and Industrial Pharmacy 45:3, pages 498-505.
Read now
Read now
Amin Ben Lassoued, Vanessa Nivaggioni & Jean Gabert. (2014) Minimal residual disease testing in hematologic malignancies and solid cancer. Expert Review of Molecular Diagnostics 14:6, pages 699-712.
Read now
Read now
S CIOLLI, AM VANNUCCHI, F LEONI, C NOZZOLI, G LONGO, A SALATI, A PANCRAZZI, L BIANCHI, F GIGLI & A BOSI. (2004) Internal Tandem Duplications of Flt3 Gene (Flt3/ITD) Predicts a Poor Post-Remission Outcome in Adult Patients with Acute Non-Promyelocytic Leukemia. Leukemia & Lymphoma 45:1, pages 73-78.
Read now
Read now
Articles from other publishers (45)
Lara J. Bou Malhab, Habiba Alsafar, Saleh Ibrahim & Mohamed Rahmani. (2023) PROTACs: Walking through hematological malignancies. Frontiers in Pharmacology 14.
Crossref
Crossref
Shengquan Hu, Jing Liu, Sikang Chen, Jian Gao, Yubo Zhou, Tao Liu & Xiaowu Dong. (2021) Discover Novel Covalent Inhibitors Targeting FLT3 through Hybrid Virtual Screening Strategy. Biological and Pharmaceutical Bulletin 44:12, pages 1872-1877.
Crossref
Crossref
Ik-Chan Song, Deog-Yeon Jo, Hyeoung-Joon Kim, Yoo-Hong Min, Dae Sik Hong, Won-Sik Lee, Ho-Jin Shin, Je-Hwan Lee, Jinny Park & Hee-Je Kim. (2021) Clinical features and outcomes of hypocellular acute myeloid leukemia in adults. Medicine 100:1, pages e24185.
Crossref
Crossref
Rong He, Daniel J. Devine, Zheng Jin Tu, Ming Mai, Dong Chen, Phuong L. Nguyen, Jennifer L. Oliveira, James D. Hoyer, Kaaren K. Reichard, Paul L. Ollila, Aref Al-Kali, Ayalew Tefferi, Kebede H. Begna, Mrinal M. Patnaik, Hassan Alkhateeb & David S. Viswanatha. (2020) Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis. Modern Pathology 33:3, pages 334-343.
Crossref
Crossref
Hitoshi Kiyoi, Naomi Kawashima & Yuichi Ishikawa. (2019)
FLT3
mutations in acute myeloid leukemia: Therapeutic paradigm beyond inhibitor development
. Cancer Science 111:2, pages 312-322.
Crossref
Crossref
Marie Brachet-Botineau, Marion Polomski, Heidi Neubauer, Ludovic Juen, Damien Hédou, Marie-Claude Viaud-Massuard, Gildas Prié & Fabrice Gouilleux. (2020) Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers. Cancers 12:1, pages 240.
Crossref
Crossref
Ye He, Liping Sun, Yongping Xu, Li Fu, Yun Li, Xubin Bao, Haoyu Fu, Chengying Xie & Liguang Lou. (2018) Combined inhibition of PI3Kδ and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia. Cancer Letters 420, pages 49-59.
Crossref
Crossref
Singkome Tima, Songyot Anuchapreeda, Chadarat Ampasavate, Cory Berkland & Siriporn Okonogi. (2017) Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells. European Journal of Pharmaceutics and Biopharmaceutics 114, pages 57-68.
Crossref
Crossref
Hitoshi Kiyoi. 2017. Chemotherapy for Leukemia. Chemotherapy for Leukemia
167
179
.
Leandro H. Gallo, Katelyn N. Nelson, April N. Meyer & Daniel J. Donoghue. (2015) Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations. Cytokine & Growth Factor Reviews 26:4, pages 425-449.
Crossref
Crossref
Ling Li Yuan, Alexa Green, Laure David, Christine Dozier, Christian Récher, Christine Didier, Jérôme Tamburini & Stéphane Manenti. (2014) Targeting CHK1 inhibits cell proliferation in FLT3-ITD positive acute myeloid leukemia. Leukemia Research 38:11, pages 1342-1349.
Crossref
Crossref
Akira Yoshida, Miyuki Ookura, Kouichi Zokumasu & Takanori Ueda. (2014) Gö6976, a FLT3 kinase inhibitor, exerts potent cytotoxic activity against acute leukemia via inhibition of survivin and MCL-1. Biochemical Pharmacology 90:1, pages 16-24.
Crossref
Crossref
L L Yuan, A S Green, S Bertoli, F Grimal, V Mansat-De Mas, C Dozier, J Tamburini, C Récher, C Didier & S Manenti. (2013) Pim kinases phosphorylate Chk1 and regulate its functions in acute myeloid leukemia. Leukemia 28:2, pages 293-301.
Crossref
Crossref
Kristin K. Deeb, Matthew T. Smonskey, HanChun DeFedericis, George Deeb, Sheila N.J. Sait, Meir Wetzler, Eunice S. Wang & Petr Starostik. (2014) Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemia. Leukemia Research Reports 3:2, pages 86-89.
Crossref
Crossref
Xiaohui Zhang & Ling Zhang. 2014. Molecular Pathology and Diagnostics of Cancer. Molecular Pathology and Diagnostics of Cancer
557
587
.
E. L. Seiser, R. Thomas, K. L. Richards, M. Kathryn Kelley, P. Moore, S. E. Suter & M. Breen. (2011) Reading between the lines: molecular characterization of five widely used canine lymphoid tumour cell lines. Veterinary and Comparative Oncology 11:1, pages 30-50.
Crossref
Crossref
Tomoki Naoe & Hitoshi Kiyoi. (2013) Gene mutations of acute myeloid leukemia in the genome era. International Journal of Hematology 97:2, pages 165-174.
Crossref
Crossref
Jeffrey S. Ross. 2013. Genomic and Personalized Medicine. Genomic and Personalized Medicine
798
819
.
Lorien J. Parker, Hisami Watanabe, Keiko Tsuganezawa, Yuri Tomabechi, Noriko Handa, Mikako Shirouzu, Hitomi Yuki, Teruki Honma, Naoko Ogawa, Tetsuo Nagano, Shigeyuki Yokoyama & Akiko Tanaka. (2012) Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitor. Acta Crystallographica Section F Structural Biology and Crystallization Communications 68:8, pages 860-866.
Crossref
Crossref
Andrea Kühnl & David Grimwade. (2012) Molecular markers in acute myeloid leukaemia. International Journal of Hematology 96:2, pages 153-163.
Crossref
Crossref
Farhad Ravandi, Keyur Patel, Rajyalakshmi Luthra, Stefan Faderl, Marina Konopleva, Tapan Kadia, Mark Brandt, Sherry Pierce, Steven Kornblau, Michael Andreeff, Xuemei Wang, Guillermo Garcia‐Manero, Jorge Cortes & Hagop Kantarjian. (2011) Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high‐dose cytarabine and idarubicin. Cancer 118:10, pages 2665-2673.
Crossref
Crossref
Shuangjie Leow, Shirley Kow‐Yin Kham, Hany Ariffin, Thuan Chong Quah & Allen Eng‐Juh Yeoh. (2011) FLT3 mutation and expression did not adversely affect clinical outcome of childhood acute leukaemia—a study of 531 Southeast Asian children by the Ma‐Spore study group. Hematological Oncology 29:4, pages 211-219.
Crossref
Crossref
Ying Xiong, Da Song, Yunfei Cai, Wenfeng Yu, Yee-Guide Yeung & E. Richard Stanley. (2011) A CSF-1 Receptor Phosphotyrosine 559 Signaling Pathway Regulates Receptor Ubiquitination and Tyrosine Phosphorylation. Journal of Biological Chemistry 286:2, pages 952-960.
Crossref
Crossref
Amer Beitinjaneh, Sekwon Jang, Henri Roukoz & Navneet S. Majhail. (2010) Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: A systematic review. Leukemia Research 34:7, pages 831-836.
Crossref
Crossref
Jeffrey S. Ross. 2010. Essentials of Genomic and Personalized Medicine. Essentials of Genomic and Personalized Medicine
532
547
.
Sergej Konoplev & Carlos Bueso-Ramos. 2010. Molecular Pathology of Hematolymphoid Diseases. Molecular Pathology of Hematolymphoid Diseases
449
462
.
Weina Chen, Sergej Konoplev, L. Jeffrey Medeiros, Hartmut Koeppen, Vasiliki Leventaki, Saroj Vadhan-Raj, Dan Jones, Hagop M. Kantarjian, Brunangelo Falini & Carlos E. Bueso-Ramos. (2009)
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with
FLT3
internal tandem duplication and
NPM1
mutation
. Cancer 115:23, pages 5481-5489.
Crossref
Crossref
Jeffrey S. Ross. 2009. Genomic and Personalized Medicine. Genomic and Personalized Medicine
990
1007
.
Ronald Feitosa Pinheiro, Eloisa de Sá Moreira, Maria Regina Régis Silva, Fernando Lopes Alberto & Maria de Lourdes L.F. Chauffaille. (2008) FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia. Cancer Genetics and Cytogenetics 183:2, pages 89-93.
Crossref
Crossref
Soo-Mee BangJeong Yeal AhnJiyoon ParkSe Hoon ParkJinny ParkEun Kyung ChoDong Bok ShinJae Hoon LeeSoo Jin YooIn Sang JeonYeo-Kyeoung KimHyeoung Joon KimHee-Nam KimIl-Kwon LeeHyoung Jin KangHee Young ShinHyo Seop Ahn. (2008) Low Frequency and Variability of FLT3 Mutations in Korean Patients with Acute Myeloid Leukemia. Journal of Korean Medical Science 23:5, pages 833.
Crossref
Crossref
Beatriz Sanchez-Vega. 2008. Molecular Biomethods Handbook. Molecular Biomethods Handbook
65
87
.
Jeffrey S. Ross. 2008. Pharmacogenomics and Personalized Medicine. Pharmacogenomics and Personalized Medicine
267
298
.
Ronald Feitosa Pinheiro, Eloisa de Sá Moreira, Maria Regina Régis Silva, Bárbara Greggio, Fernando Lopes Alberto & Maria de Lourdes L.F. Chauffaille. (2007) FLT3 mutation and AML/ETO in a case of Myelodysplastic syndrome in transformation corroborates the two hit model of leukemogenesis. Leukemia Research 31:7, pages 1015-1018.
Crossref
Crossref
Y-F Liu, Y-M Zhu, S-H Shen, Z-X Shen, J-M Li, S-J Chen, Z Chen & H U Jiong. (2006) Molecular response in acute promyelocytic leukemia: a direct comparison of regular and real-time RT-PCR. Leukemia 20:8, pages 1393-1399.
Crossref
Crossref
Hitoshi Kiyoi & Tomoki Naoe. (2006) Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation. International Journal of Hematology 83:4, pages 301-308.
Crossref
Crossref
A Thomas Look & Adolfo A Ferrando. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Weina Chen, Dan Jones, L. Jeffrey Medeiros, Rajyalashmi Luthra & Pei Lin. (2005) Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type. British Journal of Haematology 130:5, pages 726-728.
Crossref
Crossref
Hitoshi Kiyoi, Masamitsu Yanada & Kazutaka Ozekia. (2005) Clinical Significance of FLT3 in Leukemia. International Journal of Hematology 82:2, pages 85-92.
Crossref
Crossref
M Yanada, K Matsuo, T Suzuki, H Kiyoi & T Naoe. (2005) Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis. Leukemia 19:8, pages 1345-1349.
Crossref
Crossref
Y Choi, H-J Kim, B-H Park, W-S Min & C-C Kim. (2004) Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia. Leukemia 19:1, pages 141-143.
Crossref
Crossref
Jens Tiesmeier, Carsten Müller-Tidow, Annette Westermann, Andreas Czwalinna, Mandy Hoffmann, Jürgen Krauter, Gerhard Heil, Arnold Ganser, Hubert Serve & Walter Verbeek. (2004) Evolution of FLT3-ITD and D835 activating point mutations in relapsing acute myeloid leukemia and response to salvage therapy. Leukemia Research 28:10, pages 1069-1074.
Crossref
Crossref
Jeffrey S Ross. (2004) Targeted Therapy for Cancer. American Journal of Cancer 3:4, pages 205-214.
Crossref
Crossref
Jerzy Lasota, Agnieszka Dansonka-Mieszkowska, Tomasz Stachura, Regine Schneider-Stock, Markku Kallajoki, Sonja E Steigen, Maarit Sarlomo-Rikala, Carsten Boltze, Radzislaw Kordek, Albert Roessner, Jerzy Stachura & Markku Miettinen. (2003) Gastrointestinal Stromal Tumors with Internal Tandem Duplications in 3′ End of KIT Juxtamembrane Domain Occur Predominantly in Stomach and Generally Seem to Have a Favorable Course. Modern Pathology 16:12, pages 1257-1264.
Crossref
Crossref
Y Hirose, K Kudo, H Kiyoi, Y Hayashi, T Naoe & S Kojima. (2003) Comprehensive analysis of gene alterations in acute megakaryoblastic leukemia of Down's syndrome. Leukemia 17:11, pages 2250-2252.
Crossref
Crossref
G. J. M. van de Geijn, L. H. J. Aarts, S. J. Erkeland, J. M. Prasher & L. P. Touw. 2004. Reviews of Physiology, Biochemistry and Pharmacology. Reviews of Physiology, Biochemistry and Pharmacology
53
71
.